Southern Nuclear recently loaded nuclear fuel with uranium-235 enriched up to 6 percent—higher than the usual 3–5 percent enrichment—into Vogtle-2 to test it through irradiation.

French nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the industrial-scale production of the alpha-emitting medical radioisotope astatine-211 across Europe and the United States.

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.

A hybrid public meeting hosted by the Nuclear Regulatory Commission on October 30 will feature chair Christopher Hanson and commissioners David Wright, Annie Caputo, and Bradley Crowell.

The Department of Energy announced contracts yesterday for six companies to perform high-assay low-enriched uranium (HALEU) deconversion and to transform enriched uranium hexafluoride (UF₆) to other chemical forms, including metal or oxide, for storage before it is fabricated into fuel for advanced reactors. It amounts to a first round of contracting. “These contracts will allow selected companies to bid on work for deconversion services,” according to the DOE’s announcement, “creating strong competition and allowing DOE to select the best fit for future work.”

TerraPower announced May 29 that it will work with Framatome North America to fund the high-assay low-enriched uranium (HALEU) metallization pilot plant that Framatome is building at its fuel fabrication facility in Richland, Wash. A successful demonstration of Framatome’s capability of converting enriched uranium oxide to HALEU metal will “support the development of the domestic HALEU supply chain,” both companies say.

Framatome was recently awarded a multimillion-dollar contract to perform mitigation of buried condenser feed pipes at a three-unit nuclear power plant in the United States.

The France-based nuclear company plans to install spray-in-place structural pipe liner to mitigate more than one mile of large diameter underground piping connected to plant condenser boxes. The project will be performed during nine outages over eight years, with the first application planned for fall 2025.

An official groundbreaking last week at Framatome’s Mill Ridge Road facility, in Lynchburg, Va., marks the start of a $50 million expansion and an eventual addition of 500 employees, according to the nuclear company.

Bulgarian officials have approved the transition to Westinghouse fuel at the nation's Kozloduy nuclear power plant, as Bulgaria moves away from its reliance on Russian supplies. The fuel was recently delivered for use in Unit 5.

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at KHNP’s Wolsong nuclear power plant in South Korea. The companies also will investigate the feasibility of using the plant to support Korean production of medical radioisotopes in the future.

French nuclear developer Framatome is slated to deliver key equipment for Sizewell C Ltd.’s two large reactors planned for the United Kingdom’s Suffolk coast.

The agreement, reportedly worth multiple billions of euros, was announced this week and will involve Framatome from the design phase until commissioning. The company also agreed to a long-term fuel supply deal. Framatome is 80.5 percent owned by France’s EDF and 19.5 percent owned by Mitsubishi Heavy Industries.

Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177. The cooperative agreement was signed during the World Nuclear Exhibition 2023, held November 28–30 in Paris.

Framatome Inc. and Ultra Safe Nuclear Corp. (USNC) signed an agreement on November 28 at the World Nuclear Exhibition in Paris, France, establishing a joint venture to manufacture nuclear fuel for USNC’s gas-cooled microreactor and other advanced reactor designs. Working together, the companies plan to produce commercial quantities of TRISO fuel particles and USNC’s proprietary Fully Ceramic Microencapsulated (FCM) fuel, which contains TRISO fuel particles within a ceramic fuel pellet.

France-based Framatome and the Hungary’s Ministry of Energy agreed this week to strengthen their relationship in the field of nuclear energy, including in such areas as fuel supply, education, research and development, implementation of new technologies, and long-term operation.

In the latest example of Europe’s move away from its dependence on Russia for VVER reactor fuel, Westinghouse Electric Company on Friday signed a long-term agreement with Slovakia’s nuclear power plant operator, Slovenské Elektrárne, to license and supply VVER-440 fuel assemblies.

Framatome’s Protect EATF assembly. (Photo: Framatome)

The nuclear industry’s first 100 percent accident tolerant fuel assembly has successfully completed its initial cycle of operation at a U.S. nuclear power plant, Framatome announced earlier this week.

Following 24 months of operation at Constellation Energy’s two-unit Calvert Cliffs nuclear power plant in Lusby, Md., testing and inspections confirm that Framatome’s lead Enhanced Accident Tolerant Fuel (EATF) assembly safely withstood in-reactor conditions and performed as designed, according to the French-based company.

"The accelerated delivery and proven performance of our technology reflects the dedication and expertise of our people with the collaborative support from the industry,” said Lionel Gaiffe, senior executive vice president of Framatome’s fuel business unit. “Collectively, we are one step closer in the qualification of our Protect EATF technology for the nuclear industry. With the adoption and implementation of our enhanced technologies, our industry partners continue to demonstrate their commitment to enhance the safety and performance of their reliable, low-carbon, energy operations.”

Slovakia’s Slovenské Elektrárne—operator of the nation’s two nuclear power plants, Bohunice and Mochovce—and France’s Framatome have signed a memorandum of understanding for the development of a global strategic relationship, the companies announced last week.

NuScale Power announced yesterday that it has joined the Romanian Atomic Forum, aka Romatom, as a supporting member “to champion the association’s nuclear energy goals and further the next generation of advanced nuclear technology experts, technologists, and operators in Romania.” The move further deepens the American small modular reactor company’s commitment to the deployment of a VOYGR SMR plant in the Central European state.

Framatome is prepared to manufacture a novel molybdenum-uranium (U-Mo) fuel to extend the life and safe operation of the Forschungsreaktor München II (FRM II) research reactor in Germany. A new fuel supply—one that uses uranium enriched to less than 20 percent U-235—means the FRM II can continue to supply neutrons to industry and the scientific community. The fuel is “Europe’s low-enriched fuel with the highest density ever realized for research reactor operations,” according to Framatome’s April 27 announcement.